Effectiveness of different central venous catheters for catheter-related infections: A network meta-analysis

Journal of Hospital Infection

Volumn 76, Issue 1, 2010, Pages 1-11

  Wang, H ^a   Huang, T ^a   Jing, J ^a   Jin, J ^a   Wang, P ^a   Yang, M ^a   Cui, W ^a   Zheng, Y ^a   Shen, H ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Catheter colonisation; Catheter related bloodstream infection; Central venous catheter; Network meta analysis

Indexed keywords

CHLORHEXIDINE; MICONAZOLE; MINOCYCLINE; RIFAMPICIN; SULFADIAZINE SILVER;

CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MICROBIAL COLONIZATION; MONTE CARLO METHOD; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW;

EID: 77955514671     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.04.025     Document Type: Review

References (79)

1. Banerjee S.N., Emori T.G., Culver D.H., et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National nosocomial infections surveillance system. Am J Med 1991, 91:86S-89S.
2. Maki D.G. Nosocomial bacteremia. An epidemiologic overview. Am J Med 1981, 70:719-732.
3. Raad I. Intravascular-catheter-related infections. Lancet 1998, 351:893-898.
4. Edgeworth J.D., Treacher D.F., Eykyn S.J. A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 1999, 27:1421-1428.
5. Pittet D., Tarara D., Wenzel R.P. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994, 271:1598-1601.
6. Raad I., Hanna H., Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 2007, 7:645-657.
7. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002, 51:1-29.
8. Veenstra D.L., Saint S., Saha S., Lumley T., Sullivan S.D. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999, 281:261-267.
9. Walder B., Pittet D., Tramer M.R. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect Control Hosp Epidemiol 2002, 23:748-756.
10. Falagas M.E., Fragoulis K., Bliziotis I.A., Chatzinikolaou I. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2007, 59:359-369.
11. Casey A.L., Mermel L.A., Nightingale P., Elliott T.S. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 2008, 8:763-776.
12. Niel-Weise B.S., Stijnen T., van den Broek P.J. Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials. Intensive Care Med 2007, 33:2058-2068.
13. Gilbert R.E., Harden M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Curr Opin Infect Dis 2008, 21:235-245.
14. Niel-Weise B.S., Stijnen T., van den Broek P.J. Anti-infective-treated central venous catheters for total parenteral nutrition or chemotherapy: a systematic review. J Hosp Infect 2008, 69:114-123.
15. Hockenhull J.C., Dwan K.M., Smith G.W., et al. The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review. Crit Care Med 2009, 37:702-712.
16. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002, 21:2313-2324.
17. Lu G., Ades A.E. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004, 23:3105-3124.
18. Wen J., Ren Y., Wang L., et al. The reporting quality of meta-analyses improves: a random sampling study. J Clin Epidemiol 2008, 61:770-775.
19. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: the Quorom statement. Quality of reporting of meta-analyses. Lancet 1999, 354:1896-1900.
20. Cochrane handbook for systematic reviews of interventions 5.0.1 2008, Wiley, Chichester, [updated September 2008]. J.P.T. Higgins, S. Green (Eds.).
21. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
22. Shah P.S., Shah N. Heparin-bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database Syst Rev 2007, CD005983.
23. Higgins J.P.T., Altman D.G. Assessing risk of bias in included studies. Cochrane handbook for systematic reviews of interventions 5.0.1 2008, 187-241. Wiley, Chichester, [updated September 2008]. J.P.T. Higgins, S. Green (Eds.).
24. Caldwell D.M., Ades A.E., Higgins J.P. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 2005, 331:897-900.
25. Welton N.J., Caldwell D.M., Adamopoulos E., Vedhara K. Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. Am J Epidemiol 2009, 169:1158-1165.
26. Spiegelhalter D.J., Best N.G., Carlin B.R., van der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc Ser B Stat Methodol 2002, 64:583-616.
27. Edwards S.J., Clarke M.J., Wordsworth S., Welton N.J. Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison. Curr Med Res Opin 2009, 25:251-261.
28. Stettler C., Wandel S., Allemann S., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007, 370:937-948.
29. Goldschmidt H., Hahn U., Salwender H.J., et al. Prevention of catheter-related infections by silver coated central venous catheters in oncological patients. Zentralbl Bakteriol 1995, 283:215-223.
30. Appelgren P., Ransjo U., Bindslev L., Espersen F., Larm O. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Crit Care Med 1996, 24:1482-1489.
31. Bach A., Schmidt H., Bottiger B., et al. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J Antimicrob Chemother 1996, 37:315-322.
32. Ciresi D.L., Albrecht R.M., Volkers P.A., Scholten D.J. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 1996, 62:641-646.
33. Pemberton L.B., Ross V., Cuddy P., Kremer H., Fessler T., McGurk E. No difference in catheter sepsis between standard and antiseptic central venous catheters. A prospective randomized trial. Arch Surg 1996, 131:986-989.
34. van Heerden P.V., Webb S.A., Fong S., Golledge C.L., Roberts B.L., Thompson W.R. Central venous catheters revisited - infection rates and an assessment of the new fibrin analysing system brush. Anaesth Intensive Care 1996, 24:330-333.
35. George S.J., Vuddamalay P., Boscoe M.J. Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. Eur J Anaesthesiol 1997, 14:428-431.
36. Logghe C., Van Ossel C., D'Hoore W., Ezzedine H., Wauters G., Haxhe J.J. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect 1997, 37:145-156.
37. Maki D.G., Stolz S.M., Wheeler S., Mermel L.A. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997, 127:257-266.
38. Raad I., Darouiche R., Dupuis J., et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997, 127:267-274.
39. Tennenberg S., Lieser M., McCurdy B., et al. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Arch Surg 1997, 132:1348-1351.
40. Heard S.O., Wagle M., Vijayakumar E., et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998, 158:81-87.
41. Trerotola S.O., Johnson M.S., Shah H., et al. Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infection - a randomized study. Radiology 1998, 207:491-496.
42. Bach A., Eberhardt H., Frick A., Schmidt H., Bottiger B.W., Martin E. Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit Care Med 1999, 27:515-521.
43. Boswald M., Lugauer S., Regenfus A., et al. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection 1999, 27:S56-S60.
44. Collin G.R. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest 1999, 115:1632-1640.
45. Darouiche R.O., Raad I.I., Heard S.O., et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter study group. N Engl J Med 1999, 340:1-8.
46. Hannan M., Juste R.N., Umasanker S., et al. Antiseptic-bonded central venous catheters and bacterial colonisation. Anaesthesia 1999, 54:868-872.
47. Marik P.E., Abraham G., Careau P., Varon J., Fromm R.E. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 1999, 27:1128-1131.
48. Moss H.A., Tebbs S.E., Faroqui M.H., et al. A central venous catheter coated with benzalkonium chloride for the prevention of catheter-related microbial colonization. Eur J Anaesthesiol 2000, 17:680-687.
49. Pierce C.M., Wade A., Mok Q. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med 2000, 26:967-972.
50. Sheng W.H., Ko W.J., Wang J.T., Chang S.C., Hsueh P.R., Luh K.T. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. Diagn Microbiol Infect Dis 2000, 38:1-5.
51. Jaeger K., Osthaus A., Heine J., et al. Efficacy of a benzalkonium chloride-impregnated central venous catheter to prevent catheter-associated infection in cancer patients. Chemotherapy 2001, 47:50-55.
52. van Vliet J., Leusink J.A., de Jongh B.M., de Boer A. A comparison between two types of central venous catheters in the prevention of catheter-related infections: the importance of performing all the relevant cultures. Clin Intensive Care 2001, 12:135-140.
53. Stoiser B., Kofler J., Staudinger T., et al. Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters. J Hosp Infect 2002, 50:202-206.
54. Theaker C., Juste R., Lucas N., Tallboys C., Azadian B., Soni N. Comparison of bacterial colonization rates of antiseptic impregnated and pure polymer central venous catheters in the critically ill. J Hosp Infect 2002, 52:310-312.
55. Bong J.J., Kite P., Wilco M.H., McMahon M.J. Prevention of catheter related bloodstream infection by silver iontophoretic central venous catheters: a randomised controlled trial. J Clin Pathol 2003, 56:731-735.
56. Chatzinikolaou I., Finkel K., Hanna H., et al. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med 2003, 115:352-357.
57. Corral L., Nolla-Salas M., Ibanez-Nolla J., et al. A prospective, randomized study in critically ill patients using the Oligon Vantex catheter. J Hosp Infect 2003, 55:212-219.
58. Ranucci M., Isgro G., Giomarelli P.P., et al. Impact of Oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 2003, 31:52-59.
59. Brun-Buisson C., Doyon F., Sollet J.P., Cochard J.F., Cohen Y., Nitenberg G. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intensive Care Med 2004, 30:837-843.
60. Carrasco M.N., Bueno A., de las Cuevas C., et al. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Intensive Care Med 2004, 30:633-638.
61. Hanna H., Benjamin R., Chatzinikolaou I., et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol 2004, 22:3163-3171.
62. Leon C., Ruiz-Santana S., Rello J., et al. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Med 2004, 30:1891-1899.
63. Yucel N., Lefering R., Maegele M., et al. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial. J Antimicrob Chemother 2004, 54:1109-1115.
64. Darouiche R.O., Berger D.H., Khardori N., et al. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg 2005, 242:193-200.
65. Dunser M.W., Mayr A.J., Hinterberger G., et al. Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic-impregnated catheters. Anesth Analg 2005, 101:1778-1784.
66. Jaeger K., Zenz S., Juttner B., et al. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter. Ann Hematol 2005, 84:258-262.
67. Moretti E.W., Ofstead C.L., Kristy R.M., Wetzler H.P. Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia. J Hosp Infect 2005, 61:139-145.
68. Ostendorf T., Meinhold A., Harter C., et al. Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients - a double-blind, randomised, prospective, controlled trial. Support Care Cancer 2005, 13:993-1000.
69. Rupp M.E., Lisco S.J., Lipsett P.A., et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 2005, 143:570-580.
70. Fraenkel D., Rickard C., Thomas P., Faoagali J., George N., Ware R. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med 2006, 34:668-675.
71. Osma S., Kahveci S.F., Kaya F.N., et al. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit. J Hosp Infect 2006, 62:156-162.
72. Abdelkefi A., Achour W., Ben Othman T., et al. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection. J Support Oncol 2007, 5:273-278.
73. Kalfon P., de Vaumas C., Samba D., et al. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit Care Med 2007, 35:1032-1039.
74. Camargo L.F., Marra A.R., Buchele G.L., et al. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study. J Hosp Infect 2009, 72:227-233.
75. Hagau N., Studnicska D., Gavrus R.L., Csipak G., Hagau R., Slavcovici A.V. Central venous catheter colonization and catheter-related bloodstream infections in critically ill patients: a comparison between standard and silver-integrated catheters. Eur J Anaesthesiol 2009, 26:752-758.
76. Mer M., Duse A.G., Galpin J.S., Richards G.A. Central venous catheterization: a prospective, randomized, double-blind study. Clin Appl Thromb Hemost 2009, 15:19-26.
77. Sampath L.A., Tambe S.M., Modak S.M. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 2001, 22:640-646.
78. Schierholz J.M., Fleck C., Beuth J., Pulverer G. The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity. J Antimicrob Chemother 2000, 46:45-50.
79. Tambe S.M., Sampath L., Modak S.M. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001, 47:589-598.